IPG Q3 Revenue Up 15% to $287.5M; Net Income Doubles to $20.3M
IPGP is trading near its 52-week low of $68.27 (9.3% above the low).
Summary
IPG posted Q3 revenue of $287.5M (+14.6%) and net income of $20.3M ($0.47 diluted), helped by tariff refunds. The 10-Q also details a pending €300M Lumibird Medical acquisition and a ~$25M Q4 property impairment.
Key Events · Earnings and Guidance · IPGP
-
Q3 Revenue Grows 14.6%
Net sales rose to $287.5M from $250.8M a year ago, with Industrial Solutions up 11.6% and Advanced Solutions up 32.8%.
-
Net Income More Than Doubles
Net income reached $20.3M ($0.47 diluted) versus $7.5M ($0.18) a year ago; gross margin expanded to 40.7% from 39.5%.
-
Tariff Refunds Flatter Margins
$5.8M of IEEPA tariff refunds added roughly 170 basis points to Q3 gross margin — a one-time benefit, not recurring operating improvement.
-
Lumibird Deal to Draw Down Cash
The €300M (~$340.3M) cash acquisition of Lumibird Medical is expected to close in Q4 2026, plus up to €50M (~$56.7M) in earnouts, against $710.7M of cash.
Analysis · IPGP · Manufacturing
IPG's third quarter showed real operating improvement: revenue rose 14.6% to $287.5M and net income more than doubled to $20.3M ($0.47 diluted), with gross margin expanding to 40.7% from 39.5%. Part of that margin gain is one-time help — $5.8M of IEEPA tariff refunds added roughly 170 basis points — so the underlying improvement is smaller than the headline. The bigger story for the balance sheet is what comes next: the €300M (~$340.3M) cash purchase of Lumibird Medical is expected to close in Q4 2026, and the company also flagged an estimated ~$25M pre-tax impairment on properties approved for sale on October 30, 2026. Cash of $710.7M is ample to fund the deal, but it will meaningfully draw down near-term liquidity.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IPGP was trading at $74.65 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $3.2B. The 52-week trading range was $68.27 to $155.82. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.